Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Income from Continuing Operations: 2019-2024

Historic Income from Continuing Operations for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to -$259.6 million.

  • Maravai Lifesciences Holdings' Income from Continuing Operations rose 73.87% to -$45.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213.8 million, marking a year-over-year increase of 33.91%. This contributed to the annual value of -$259.6 million for FY2024, which is 87.62% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Income from Continuing Operations of -$259.6 million as of FY2024, which was down 87.62% from -$138.4 million recorded in FY2023.
  • Maravai Lifesciences Holdings' 5-year Income from Continuing Operations high stood at $490.7 million for FY2022, and its period low was -$259.6 million during FY2024.
  • Its 3-year average for Income from Continuing Operations is $30.9 million, with a median of -$138.4 million in 2023.
  • In the last 5 years, Maravai Lifesciences Holdings' Income from Continuing Operations soared by 1,615.40% in 2020 and then tumbled by 128.20% in 2023.
  • Maravai Lifesciences Holdings' Income from Continuing Operations (Yearly) stood at $78.8 million in 2020, then skyrocketed by 495.37% to $469.2 million in 2021, then grew by 4.56% to $490.7 million in 2022, then slumped by 128.20% to -$138.4 million in 2023, then plummeted by 87.62% to -$259.6 million in 2024.